Evaluation of clinical usefulness of second-generation HCV core antigen assay: Comparison with COBAS AMPLICOR HCV MONITOR assay version 2.0

Osamu Yokosuka, Shigenobu Kawai, Yoichi Suzuki, Kenichi Fukai, Fumio Imazeki, Tatsuo Kanda, Motohisa Tada, Rintarou Mikata, Akira Hata, Hiromitsu Saisho

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Abstract

Background: Hepatitis C virus (HCV) is an important etiologic agent for chronic liver diseases. Methods: The aim of this study was to evaluate the clinical usefulness of second-generation HCV core antigen assay by comparing the results of the assay with those of the COBAS AMPLICOR HCV MONITOR version 2.0 (COBAS v2.0). Results: HCV core antigen was detectable by this assay in 142/149 (95.3 %) of serotype 1 (3821 ±322 fmol/1; mean ± SD), in 56/58 (96.6%) of serotype 2 (2589 ± 449 fmol/1), and in 6/6 (100%) of serotypes 1+2 (1240 ± 548 fmol/1). The HCV core antigen levels measured by this assay correlated well with the HCV RNA levels by COBAS v2.0 (r = 0. 848, P < 0.0001). In relation to the outcome of interferon monotherapy, the pretreatment HCV core antigen levels of sustained and non-sustained virological responders were 659 ± 189 and 4904 ± 376 fmol/1 in serotype 1, 1993 ± 740 and 3145 ± 519 fmol/1 in serotype 2. The cutoff values with the best accuracy for HCV core Ag levels to discriminate between sustained and non-sustained virological response were 699 frnol/1 for serotype 1 and 292 fmol/1 for serotype 2, respectively, by receiver operating characteristic curve analysis. Conclusion: This new assay was considered to be useful in evaluating the HCV levels in patients with chronic hepatitis C.

Original languageEnglish
Pages (from-to)1136-1141
Number of pages6
JournalLiver International
Volume25
Issue number6
DOIs
Publication statusPublished - 2005 Dec 1

Keywords

  • Hepatitis C virus
  • Interferon
  • Polymerase chain reaction
  • Viral load

ASJC Scopus subject areas

  • Hepatology

Fingerprint Dive into the research topics of 'Evaluation of clinical usefulness of second-generation HCV core antigen assay: Comparison with COBAS AMPLICOR HCV MONITOR assay version 2.0'. Together they form a unique fingerprint.

Cite this